Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An X-linked recessive immunologic disorder characterized by the onset of recurrent sinopulmonary, mucosal, and other infections in early childhood, usually accompanied by refractory autoimmune cytopenias. Affected individuals have bacterial, viral, and fungal infections, as well as hemolytic anemia, thrombocytopenia, lymphopenia, and decreased NK cells. Laboratory studies show defective T-cell proliferation and function, likely due to signaling abnormalities. The disorder may also manifest as a hyperinflammatory state with immune dysregulation.
Features include always present findings: Decreased naive CD4+ T cell proportion, Recurrent lower respiratory tract infections, Reduced total natural killer cell count, and Partial absence of specific antibody response to unconjugated pneumococcus vaccine and others; and very common findings: Decreased circulating total IgM. 31 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 7 |
SASH3 function has not been fully characterized.
Immunodeficiency 102 is associated with mutations in the SASH3 gene on chromosome X.
Genetic testing for SASH3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for immunodeficiency 102 has been reported in the published literature.
Phenotype severity distribution: 12 always present features, 1 very common feature, 16 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for immunodeficiency 102.
201 publications have been identified in PubMed for immunodeficiency 102. Kisho has analyzed 107 by research type. Research spans Epidemiology / Natural History (49%), Review / Meta-Analysis (13%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 52 | 49% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 6:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Lungs and breathing | 4 | Recurrent lower respiratory tract infections, Partial absence of specific antibody response to unconjugated pneumococcus vaccine, Bronchiectasis |
Lab test results | 3 | Partial absence of specific antibody response to Haemophilus influenzae type b (Hib) vaccine, Partial absence of specific antibody response to unconjugated pneumococcus vaccine, Increased circulating interleukin 6 concentration |
Digestive system | 2 | Enlarged liver (hepatomegaly), Nodular regenerative hyperplasia of liver |
Skin | 1 | Recurrent skin infections |
Hormones | 1 | Hypothyroidism |
Research summaries
14 |
13% |
Clinical study results | 13 | 12% |
Testing and diagnosis research | 9 | 8% |
Patient case studies | 9 | 8% |
Laboratory research | 7 | 7% |
New treatment approaches | 3 | 3% |
Ellis J (2026). [PMID: 41662846](https://pubmed.ncbi.nlm.nih.gov/41662846/). *Lancet HIV*. [Clinical Trial Publication]
Ullah S (2026). [PMID: 41205761](https://pubmed.ncbi.nlm.nih.gov/41205761/). *J Virol Methods*. [Diagnostic / Biomarker]
Chen J (2026). [PMID: 41767535](https://pubmed.ncbi.nlm.nih.gov/41767535/). *Front Med (Lausanne)*. [Case Report / Case Series]
Wu J (2026). [PMID: 42138354](https://pubmed.ncbi.nlm.nih.gov/42138354/). *J Int Assoc Provid AIDS Care*. [Epidemiology / Natural History]
Chaurasia R (2026). [PMID: 41125254](https://pubmed.ncbi.nlm.nih.gov/41125254/). *Vox Sang*. [Review / Meta-Analysis]
Herter J (2026). [PMID: 41519759](https://pubmed.ncbi.nlm.nih.gov/41519759/). *BMC Med*. [Clinical Trial Publication]
Almahfoud M (2026). [PMID: 41137996](https://pubmed.ncbi.nlm.nih.gov/41137996/). *Infection*. [Epidemiology / Natural History]
Tieosapjaroen W (2026). [PMID: 40744527](https://pubmed.ncbi.nlm.nih.gov/40744527/). *Sex Transm Infect*. [Epidemiology / Natural History]
Konan B (2026). [PMID: 41891492](https://pubmed.ncbi.nlm.nih.gov/41891492/). *J Med Virol*. [Clinical Trial Publication]
Azoulay E (2026). [PMID: 41856149](https://pubmed.ncbi.nlm.nih.gov/41856149/). *Lancet Respir Med*. [Clinical Trial Publication]